Clinical trial
Localised Cancer of Prostate and Androgen Deficiency.
NCT02235142 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Localised Cancer of Prostate and Androgen Deficiency.
- Lead sponsor
- Hopital Foch
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 3, 2013
- Completion date
- December 22, 2021
- Enrollment
- 1,614 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of prostate